JNJ vs SLB: Which Is the Better Buy?

Side-by-side comparison of Johnson & Johnson and SLB N.V. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-25.
Johnson & Johnson ยท Healthcare
$230.69
+10.8% upside to fair value
Grade C High Quality
VS
SLB N.V. ยท Energy
$56.15
+45.0% upside to fair value
Grade B
QuantHub Verdict
SLB has more upside to fair value (+45.0%). SLB trades at a lower forward P/E (24.3x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric JNJ SLB
Current Price $230.69 $56.15
Fair Value Estimate $255.61 $81.42
Upside to Fair Value +10.8% +45.0%
Market Cap $555.9B $84.3B
Forward P/E 26.8x 24.3x
EV / EBITDA 18.5x 17.5x
Price / Sales 5.8x 2.4x
Price / FCF 28.2x 17.6x
Revenue Growth YoY +9.9% +2.7%
Gross Margin 69.1% 13.6%
Operating Margin 26.9% 11.5%
Return on Equity 26.5% 12.2%
Dividend Yield 0% 0%
FCF Yield 3.54% 5.69%
Analyst Consensus Buy Strong Buy
Investment Thesis
JNJ โ€” Johnson & Johnson
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,โ€ฆ
SLB โ€” SLB N.V.
SLB N.V. is the world's largest oilfield services company operating primarily in the energy sector with a focus on oil and gas equipment and services. The company benefits from a diversified revenue base across well construction, production systems, reservoir characterization, and digital integration, with fiscal year 2024 revenues totaling over $37 billion. Despite modest revenue growth of 2.7% โ€ฆ
Accumulation Zones
Metric JNJ SLB
Zone Low $191.71 $61.06
Zone High $217.27 $69.21
In Buy Zone? No Yes
โ† JNJ Research    SLB Research โ†’    All Research